A 2021 update on syphilis: Taking stock from pathogenesis to vaccines

21Citations
Citations of this article
185Readers
Mendeley users who have this article in their library.

Abstract

In 2021 the scientific community’s efforts have been focused on solving the back-breaking challenge of the COVID-19 pandemic, but sexually transmitted infections (STI) are still one of the most common global health problems. Syphilis is a systemic disease caused by the spirochaete Treponema pallidum (TP) and is one of the oldest known diseases. Its incidence has increased in the last few years and syphilis still remains a contemporary plague that continues to afflict millions of people worldwide. Despite research improvements, syphilis pathogenesis is not completely clear; clinical presentation is very heterogeneous and the diagnosis can sometimes be difficult. Furthermore, few therapeutic options are available, and a vaccine has not been found yet. In this review, we describe the most recent evidence concerning the clinical manifestation, diagnosis, treatment and vaccine prospectives for this disease.

Cite

CITATION STYLE

APA

Tiecco, G., Antoni, M. D., Storti, S., Marchese, V., Focà, E., Torti, C., … Quiros-Roldan, E. (2021, November 1). A 2021 update on syphilis: Taking stock from pathogenesis to vaccines. Pathogens. MDPI. https://doi.org/10.3390/pathogens10111364

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free